Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Aldeyra Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +10 vs. Q1 2023
- Shares held
- 39.0M
- +3.47M (+9.7%) vs. Q1 2023
- Total value
- $327.5M
- −$25.8M (−7.3%) vs. Q1 2023
- New holders
- 41
- 34 more added
- Sold out
- 31
- 27 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $77.7M |
| Q1 2026 | 128 | $63.3M |
| Q4 2025 | 136 | $201.8M |
| Q3 2025 | 131 | $204.2M |
| Q2 2025 | 122 | $130.8M |
| Q1 2025 | 126 | $215.5M |
| Q4 2024 | 119 | $185.6M |
| Q3 2024 | 112 | $196.4M |
| Q2 2024 | 103 | $116.9M |
| Q1 2024 | 101 | $115.8M |
| Q4 2023 | 105 | $123.3M |
| Q3 2023 | 120 | $252.3M |
| Q2 2023 | 119 | $327.5M |
| Q1 2023 | 109 | $353.4M |
| Q4 2022 | 96 | $237.9M |
| Q3 2022 | 89 | $197.4M |
| Q2 2022 | 95 | $147.5M |
| Q1 2022 | 111 | $171.8M |
| Q4 2021 | 115 | $146.7M |
| Q3 2021 | 117 | $348.9M |
| Q2 2021 | 136 | $512.8M |
| Q1 2021 | 108 | $376.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Aldeyra Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 305,356 | $2.56M | 0.00% | +57,956+23.4% | Added |
| Morgan Stanley | 321,028 | $2.69M | 0.00% | −858,935−72.8% | Reduced |
| Wells Fargo & Company | 339,876 | $2.85M | 0.00% | +68,033+25.0% | Added |
| Johnson & Johnson | 394,834 | $3.31M | 1.03% | 00.0% | Unchanged |
| Northern Trust Corp | 413,676 | $3.47M | 0.00% | +328,190+383.9% | Added |
| Two Sigma Advisers, LP | 434,000 | $3.64M | 0.01% | −93,900−17.8% | Reduced |
| Millennium Management LLC | 495,575 | $4.16M | 0.00% | −622,856−55.7% | Reduced |
| Invesco Ltd. | 515,341 | $4.32M | 0.00% | +232,635+82.3% | Added |
| FMR LLC | 681,258 | $5.72M | 0.00% | −107,531−13.6% | Reduced |
| Verition Fund Management LLC | 930,074 | $7.80M | 0.12% | −634,954−40.6% | Reduced |
| Geode Capital Management, LLC | 953,250 | $8.00M | 0.00% | +464,905+95.2% | Added |
| Laurion Capital Management LP | 1,001,377 | $8.40M | 0.36% | +44,477+4.6% | Added |
| Eagle Asset Management Inc | 1,058,546 | $8.88M | 0.05% | −785,464−42.6% | Reduced |
| Dimensional Fund Advisors LP | 1,125,645 | $9.44M | 0.00% | +2,737+0.2% | Added |
| Knoll Capital Management, LLC | 3,015,668 | $25.3M | 30.98% | +948,508+45.9% | Added |
| State Street Corp | 3,041,866 | $25.5M | 0.00% | +2,868,585+1,655.5% | Added |
| Vanguard Group Inc | 3,180,194 | $26.7M | 0.00% | +681,033+27.3% | Added |
| BlackRock Inc. | 3,230,414 | $27.1M | 0.00% | +2,245,432+228.0% | Added |
| Perceptive Advisors LLC | 11,350,085 | $95.2M | 2.77% | 00.0% | Unchanged |
| Natixis | 0 | $0 | 0.00% | −674,549−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −645,020−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −253,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −211,388−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −135,894−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100,909−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −78,556−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −67,325−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −67,048−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −36,643−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −32,510−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −25,585−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −24,903−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −24,787−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −23,317−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −22,575−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Laidlaw Wealth Management LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −16,521−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −14,879−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −10,771−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −10,370−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −9,430−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −8,510−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −7,149−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,757−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −3,223−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |